Flortaucipir

CHEMBL3546271 Phase 4 अनुमोदित Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

263.3 g/mol

LogP

3.3

Phase

4

This PET imaging agent binds to tau protein tangles in the brain, which are a hallmark of Alzheimer's disease and other tauopathies.

आणविक भार

263.2700 g/mol

LogP

3.30

TPSA

41.60 Å²

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

Alzheimer's Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure

Embed this structure

SMILES

Fc1ccc(-c2ccc3c(c2)[nH]c2ccncc23)cn1

InChI

InChI=1S/C16H10FN3/c17-16-4-2-11(8-19-16)10-1-3-12-13-9-18-6-5-14(13)20-15(12)7-10/h1-9,20H

Molecular Formula

C16H10FN3

HBD / HBA

1 / 3

घूर्णनीय बंधन

1

भारी परमाणु

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

This PET imaging agent binds to tau protein tangles in the brain, which are a hallmark of Alzheimer's disease and other tauopathies.

Yes, Flortaucipir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3546271. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 71059746. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

रोगी-अनुकूल जानकारी खोज रहे हैं?

Flortaucipir PillFYI पर

संरचना

त्वरित डेटा

सूत्र: C16H10FN3
पर्यायवाची: 1

बाहरी लिंक

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.